A SINGLE-CENTRE, PILOT, RANDOMISED CONTROLLED TRIAL OF RECOMBINANT HUMAN ERYTHROPOIETIN IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS

Authors
Category Primary study
JournalJOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Year 2010
This article has no abstract
Epistemonikos ID: 4a82b93e7ef19059f8f5f0850b296e10d2aaff20
First added on: Mar 31, 2022